Tradestie Institutional Equity Comparison Engine
LMRI vs CDNL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LMRI Overall Edge
LMRI Captures Institutional Edge (1โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to LMRI (LMRI) driven by superior Momentum & Technical. Fundamentally, LMRI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CDNL at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, LMRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CDNL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
LMRI N/M vs CDNL N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
LMRI
1Y -23.0% vs -79.6% ยท 52W Pos 60% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
LMRI
US Equity
LMRI
Institutional Equity
$14.26
+1.42% 1D
Market Cap
N/A
1M Return
+30.95%
1Y Return
-23.0%
Forward P/E
N/M
Unified AI Score
32.1 / 100
SELL
Tech 50.0
Fund 30.0
Flow 50.0
Mom 50.0
CDNL
US Equity
CDNL
Institutional Equity
$4.75
-8.4% 1D
Market Cap
N/A
1M Return
-65.34%
1Y Return
-79.57%
Forward P/E
N/M
Unified AI Score
44.2 / 100
HOLD
Tech 45.0
Fund 42.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
LMRI -23.0%
CDNL -79.57%
Spread: +58.25 pp (LMRI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
LMRI TTM Op. Margin: N/A
CDNL TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LMRI vs CDNL. Trailing 12-month operating profitability (LMRI N/A vs CDNL N/A) and valuation multiples (LMRI N/M vs CDNL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LMRI | CDNL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 60% ($6โ$19) | 0% ($5โ$96) | Stronger Trend | LMRI |
| Beta / 30D Volatility Risk Regime | 1.22ฮฒ ยท 85% Vol | 2.65ฮฒ ยท 238% Vol | Lower Realized Risk | LMRI |
| Unified Institutional Score Composite Signal | 32.1 / 100 (SELL) | 44.2 / 100 (HOLD) | Higher Composite | CDNL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full LMRI vs CDNL Buy Guide
LMRI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CDNL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither LMRI nor CDNL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.